Adverse Event Clinical Research R4 Backport, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-backport-ig/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
Generated Narrative: MedicationAdministration
Resource MedicationAdministration "medication-administration-tucatinib-reduced"
status: completed
medication: tucatinib 150 MG Oral Tablet (RxNorm#2361290)
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
effective: 2020-05-20
Actor |
Practitioner/practitioner-oncology-nurse-jane " NURSE" |
request: MedicationRequest/medication-request-example-tucatinib
note: Patient took 1 tablet 2x daily (By Practitioner/practitioner-oncology-nurse-jane @2020-05-20)
Route | Dose |
Oral route (qualifier value) (SNOMED CT#26643006) | 250 MG (Details: UCUM code MG = 'MG') |